dexamethasone 21-phosphate has been researched along with Lung Diseases, Obstructive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigi, L; Cenerini, L; Magnani, M; Panzani, I; Picardi, F; Rossi, L; Serafini, S | 1 |
1 trial(s) available for dexamethasone 21-phosphate and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Chronic Disease; Dexamethasone; Drug Administration Schedule; Drug Carriers; Drug Delivery Systems; Erythrocytes; Humans; Lung Diseases, Obstructive; Middle Aged | 2001 |